Standard BioTools (LAB) Announces Preliminary Fourth Quarter and Full Year 2023 Revenue
Go back to Standard BioTools (LAB) Announces Preliminary Fourth Quarter and Full Year 2023 Revenue| Labranche & Co (NASDAQ: LAB) | Delayed: 0.67 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $0.67 | 52 Week High | $4.47 | |||
| Open | $0.67 | 52 Week Low | $3.02 | |||
| Day High | $0.67 | P/E | N/A | |||
| Day Low | $0.67 | EPS | $-1.56 | |||
| Volume | 138 | |||||

